BioCentury
ARTICLE | Clinical News

Revascor mesenchymal precursor cells regulatory update

July 26, 2010 7:00 AM UTC

The Australian Therapeutic Goods Administration ( TGA) approved Mesoblast's Mesenchymal Precursor Cell (MPC) products for use in the repair and regeneration of damaged tissue. Mesoblast said it will i...